Third award of the year for Randox Laboratories

PRLog (Press Release) – Randox received the Frost & Sullivan European Technology Innovation of the Year Award for the Biochip Array Technology system, Evidence. Evidence, developed and manufactured by Randox, is the world’s first fully automated Biochip Array Technology system. Evidence is a high throughput analyser with a novel approach to immunoassay testing. The biochip is the core of Biochip Array Technology. Each biochip holds an array of up to 25 reaction sites within its diminutive 9mm2 surface. A different test is simultaneously performed at each site in the array, for multi-analyte testing in a single sample. Multi-analyte testing has both time-saving and cost-saving benefits, resulting in a more rapid and accurate diagnosis while minimising biological variation. Clinical centres as far afield as the US, Austria, China, Greece and Turkey are already using Evidence to improve their clinical diagnostic ability.

Each Biochip Array features a panel of related tests: disease-orientated arrays, screening tests or panels for clinical research. The Cardiac Array, for the early detection of heart attacks, is an example of a disease-orientated array. Screening tests take two forms: Drugs of Abuse Arrays for drug screening in employee testing or sports testing; and Drug Residues Arrays for use in food production. The Cytokines Arrays and the Adhesion Molecules Array have a range of applications in all stages of clinical research. Randox have added DNA assays to the portfolio of Biochip Array Technology tests with the launch of RanplexCRC, an array for the early detection of colorectal cancer. Randox currently have 97 biochip tests and hope to increase this to 165 by the end of 2007.

Frost & Sullivan concluded, “Randox’s multi-analyte biochip array system will raise the bar for testing and will provide laboratories with the best technology available. As the trend in today’s diagnostic approaches moves towards evidence-based diagnostics and multiparameter testing, Evidence provides clinical laboratories worldwide with a rapid and easily affordable alternative to their existing instrumentation.”

About Frost & Sullivan
Frost & Sullivan are a global growth consulting company, partnering with clients to support the development of innovative strategies for more than 40 years. The company’s industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics.